Smith Robert Joseph has filed 6 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 300000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Smith Robert Joseph | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 68,053,607 | 9999.99% | 0.18% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Smith Robert Joseph | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 200,000.0000 | 6,726,999 | 166.67% | 1.86% |
| March 14, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Smith Robert Joseph | Director | A | Stock Option (Right to Purchase Common Stock) | 75000 | $0.00 | 75,000.0000 | 6,358,237 | 9999.99% | 1.18% |